CD8A and COVID-19: In the context of the COVID-19 pandemic, cellular immune response mediated by CD8+ T cells specific to cross-reactive epitopes from common coronaviruses has been reported as one of the main determinants of immunological protection in SARS-CoV-2 infection (66).